002773 康弘藥業
按盤價 
17.180 -0.150 (-0.866%)
17.180 -0.150 (-0.866%) | 2023/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | 2019/12 人民幣(K¥) | ||
| 營業總收入 | 2,998,813 | 13.96% | 3,389,028 | 3,605,347 | 3,295,430 | 3,257,430 | |
| 減：營業總成本 | 2,065,540 | 12.67% | 2,475,902 | 3,165,611 | 3,916,647 | 2,532,169 | |
| 其中:營業成本 | 326,426 | 12.74% | 388,035 | 354,606 | 329,737 | 263,849 | |
| 財務費用 | (39,418) | 32.20% | (44,944) | (34,328) | (26,982) | (30,741) | |
| 資產減值損失 | 127 | -113.11% | (4,127) | (216,033) | (507) | (892) | |
| 公允價值變動收益 | (218) | -- | -- | -- | -- | -- | |
| 投資收益 | 21,843 | 12.56% | 38,064 | 26,426 | 34,088 | 23,262 | |
| 其中：對聯營企業和合營企業的投資收益 | (253) | -40.48% | (748) | (620) | (456) | (693) | |
| 營業利潤 | 995,370 | 14.45% | 1,015,368 | 355,177 | (512,288) | 820,753 | |
| 利潤總額 | 982,201 | 12.27% | 1,030,296 | 393,420 | (519,513) | 835,179 | |
| 減：所得稅費用 | 165,994 | 32.90% | 164,485 | (27,660) | (249,660) | 116,989 | |
| 淨利潤 | 816,207 | 8.83% | 865,811 | 421,081 | (269,853) | 718,190 | |
| 減：非控股權益 | (9,154) | 93.18% | (30,859) | (4) | -- | -- | |
| 股東淨利潤 | 825,361 | 9.36% | 896,670 | 421,084 | (269,853) | 718,190 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.900 | 9.76% | 0.980 | 0.460 | -0.310 | 0.822 | |
| 每股派息 (元) * | -- | -- | 0.150 | 0.100 | 0.100 | 0.280 | |
| 每股淨資產 (元) * | 8.247 | 12.20% | 7.506 | 6.623 | 6.246 | 5.277 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | -- | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 18/04/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
